Antithrombotic Treatment of Embolic Stroke of Undetermined Source
Hans‐Christoph Diener(University of Birmingham), Wolf-Rüdiger Schäbitz(Heidelberg University), Waltraud Pfeilschifter(Goethe University Frankfurt), Sven Poli(Hertie Institute for Clinical Brain Research), Christopher B. Granger(Clinical Research Institute), Martina Brueckmann, Michael Brainin(Universität für Weiterbildung Krems), Truman J. Milling(Population Health Research Institute), Timothy Kleinig(Royal Adelaide Hospital), Daniel Šaňák(Palacký University Olomouc), Zuzana Gdovinová(University of Pavol Jozef Šafárik), Michal Reif, Philippe Lyrer(University of Basel), Sheila Cristina Ouriques Martins(Universidade Federal do Rio Grande do Sul), Eva Kleine(Boehringer Ingelheim (Germany)), J. Donald Easton(University of California, San Francisco), Michal Bar(University Hospital Ostrava), David Z. Rose(University of South Florida), Claudia Grauer(Boehringer Ingelheim (Germany)), Juliane Meyerhoff(Boehringer Ingelheim (Germany)), Richard A. Bernstein(Northwestern University), Ralph L. Sacco(University of Miami), Geoffrey A. Donnan(The Royal Melbourne Hospital), Lisa Cronin(Boehringer Ingelheim (Germany))
Cited by 34
Related Papers
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
|The Lancet|2016|7.6k
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
|New England Journal of Medicine|2015|5.8k
Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
|New England Journal of Medicine|2015|5.1k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k